Skip to main content

Table 3 Adverse events among patients treated with Artemisinin-Naphthoquine

From: Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in calabar, Nigeria

Adverse events

Frequency (%)

Group A

Group B

Group C

N = 36

N = 35

N = 50

Weakness

4 (11.1)

1 (2.86)

7 (14.0)

Itching

1 (2.77)

3 (8.57)

0

Joint pains

1 (2.77)

0

1 (2.0)

Tingling sensation in the head

1 (2.77)

0

0

Headache

3 (8.33)

3 (8.57)

10 (20.0)

Body pains

0

1 (2.86)

1 (2.0)

Catarrh

0

1 (2.86)

2 (4.0)

Nausea

0

2 (5.71)

0

Vomiting

0

1 (2.86)

0

Swollen fingers and feet

0

1 (2.86)

0

Bitter taste

1 (2.77)

1 (2.86)

2 (4.0)

Palpitation

0

1 (2.86)

0

Cold

0

1 (2.86)

0

Hearing impairment

0

1 (2.86)

0

Dizziness

1 (2.77)

1 (2.86)

2 (4.0)

Blisters on lips

0

1 (2.86)

0

Loss of appetite

0

0

1 (2.0)

Drowsy

1 (2.77)

0

0

Cough

0

1 (2.86)

1 (2.0)

Throat itch

0

0

1 (2.0)

Heaviness on stomach

0

0

1 (2.0)

Throat pain

0

1 (2.86)

0

Diarrhoea

0

1 (2.86)

0

Waist pain

0

1 (2.86)

0